Skip to content

A randomized, double-blind, placebo-controlled clinical trial of melatonin combined with acitretin in the treatment of children with generalized pustular psoriasis

A randomized, double-blind, placebo-controlled clinical trial of melatonin combined with acitretin in the treatment of children with generalized pustular psoriasis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044690
Enrollment
Unknown
Registered
2021-03-25
Start date
2021-04-01
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized pustular psoriasis

Interventions

Experimental group:Acitretin combined with melatonin
Control group:Acitretin combined with cooked flour

Sponsors

Department of Dermatology, Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Children with clinical and pathological diagnosis of GPP; Age 0-18 years; Patients with indications of oral ACITRETIN; Severity (Psoriasis Area Severity Index, PASI) >10 points; Blood routine examination, liver and kidney function, blood lipids, blood glucose, electrolytes were normal; The difference between biological age (bone age) and life age is less than 1 year; Patients who had previously been treated with ACITRETIN but relapsed after withdrawal or reduction; Signed informed consent and full cooperation.

Exclusion criteria

Exclusion criteria: There are physical defects, such as polydactyly, deafness, blindness and congenital heart defect; there are other major diseases, such as malignant tumors, immunodeficiency, etc. There are also severe or chronic infections, such as tuberculosis, Hepatitis B, pneumonia, etc.

Design outcomes

Primary

MeasureTime frame
Severity score;Recurrence rate;Safety;

Countries

China

Contacts

Public ContactHuan Yang

Department of Dermatology, Children's Hospital of Chongqing Medical University

dinabill@163.com+86 23 63638830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026